DOLBY LABORATORIES INC-CL A (DLB) Stock Income Statement
USA - New York Stock Exchange - NYSE:DLB - US25659T1079 - Common Stock
66.38 USD
+0.07 (+0.11%)
| 2025 (2025-9-26) | 2024 (2024-9-27) | 2023 (2023-9-29) | 2022 (2022-9-30) | 2021 (2021-9-24) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.35B | 1.27B | 1.30B | 1.25B | 1.28B | |||
| Minority Interest Expense | -1.47M | -2.49M | -1.00M | 200.00K | -7.60M | |||
| Cost Of Goods | 160.13M | 140.50M | 152.60M | 141.40M | 130.00M | |||
| Gross Profit | 1.19B | 1.13B | 1.15B | 1.11B | 1.15B | |||
| Operating Expenses | 909.03M | 868.51M | 884.30M | 895.20M | 810.50M | |||
| Research and Development | 261.79M | 263.66M | 271.50M | 261.20M | 253.60M | |||
| Selling, General, and Administrative Expenses | 647.24M | 604.85M | 612.80M | 634.00M | 556.80M | |||
| Operating Income | 279.97M | 264.71M | 262.90M | 217.20M | 340.80M | |||
| Interest Income/Expense | 40.73M | 50.08M | 28.60M | 4.90M | 2.30M | |||
| Other Income/Expense | -2.20M | 4.08M | 5.70M | 3.80M | 7.90M | |||
| Non Recurring Items | -15.01M | -6.38M | -47.10M | -10.60M | 3.60M | |||
| Income Before Taxes | 303.49M | 312.48M | 250.10M | 215.30M | 354.50M | |||
| Income Tax | 46.99M | 48.16M | 48.40M | 31.40M | 36.70M | |||
| Net Income | 255.02M | 261.82M | 200.70M | 184.10M | 310.20M | |||
| EBITDA | 367.79M | 340.27M | 345.50M | 305.70M | 436.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.62 | 2.69 | 2.05 | 1.81 | 2.97 | |||
| Non GAAP EPS | 4.25 | 3.80 | 3.57 | 3.15 | 3.68 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.13% | 88.97% | 88.27% | 88.72% | 89.85% | |||
| Profit Margin | 18.90% | 20.56% | 15.44% | 14.68% | 24.21% | |||
| Operating Profit Margin | 20.75% | 20.78% | 20.23% | 17.32% | 26.60% | |||
All data in USD